Transplantation of Human Menstrual Blood Progenitor Cells Improves Hyperglycemia by Promoting Endogenous Progenitor Differentiation in Type 1 Diabetic Mice
Restricted accessResearch articleFirst published online June, 2014
Transplantation of Human Menstrual Blood Progenitor Cells Improves Hyperglycemia by Promoting Endogenous Progenitor Differentiation in Type 1 Diabetic Mice
Recently, a unique population of progenitor cells was isolated from human menstrual blood. The human menstrual blood progenitor cells (MBPCs) possess many advantages, such as the noninvasive acquisition procedure, broad multipotency, a higher proliferative rate, and low immunogenicity, and have attracted extensive attention in regenerative medicine. Preclinical studies to test the safety and efficacy of MBPCs have been underway in several animal models. However, relevant studies in type 1 diabetes mellitus (T1DM) have not yet been proceeded. Herein, we studied the therapeutic effect of MBPCs and the mechanism of β-cell regeneration after MBPC transplantation in the T1DM model. Intravenous injection of MBPCs can reverse hyperglycemia and weight loss, prolong lifespan, and increase insulin production in diabetic mice. Histological and immunohistochemistry analyses indicated that T1DM mice with MBPC transplantation recovered islet structures and increased the β-cell number. We further analyzed in vivo distribution of MBPCs and discovered that a majority of MBPCs migrated into damaged pancreas and located at the islet, duct, and exocrine tissue. MBPCs did not differentiate into insulin-producing cells, but enhanced neurogenin3 (ngn3) expression, which represented endocrine progenitors that were activated. Ngn3+ cells were not only in the ductal epithelium, but also in the islet and exocrine tissue. We analyzed a series of genes associated with the embryonic mode of β-cell development by real-time polymerase chain reaction and the results showed that the levels of those gene expressions all increased after cell transplantation. According to the results, we concluded that MBPCs stimulated β-cell regeneration through promoting differentiation of endogenous progenitor cells.
Get full access to this article
View all access options for this article.
References
1.
LoomansCJ, de KoningEJ, StaalFJ, RookmaakerMB, VerseydenC, de BoerHC, VerhaarMC, BraamB, RabelinkTJ and van ZonneveldAJ. (2004). Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 53:196–199.
2.
LaingSP, SwerdlowAJ, SlaterSD, BurdenAC, MorrisA, WaughNR, GatlingW, BingleyPJ and PattersonCC. (2003). Mortality from heat diseases in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia, 46:760–765.
3.
RyanEA, PatyBW, SeniorPA, BigamD, AlfadhliE, KnetemanNM, LakeyJR and ShapiroAM. (2005). Five-year follow-up after clinical islet transplantation. Diabetes, 54:2060–2069.
4.
ShapiroAM, LakeyJR, RyanEA, KorbuttGS, TothE, WarnockGL, KnetemanNM and RajotteRV. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 343:230–238.
5.
EzquerFE, EzquerME, ParrauDB, CarpioD, YañezAJ and CongetPA. (2008). Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant, 14:631–640.
6.
LeeRH, SeoMJ, RegerRL, SpeesJL, PulinAA, OlsonSD and ProckopDJ. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A, 103:17438–17443.
7.
EndeN, ChenR and ReddiAS. (2004). Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun, 325:665–669.
8.
EndeN, ChenR and ReddiAS. (2004). Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun, 321:168–171.
9.
BakshD, YaoR and TuanRS. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25:1384–1392.
10.
KernS, EichlerH, StoeveJ, KlüterH and BiebackK. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24:1294–1301.
11.
StenderupK, JustesenJ, ClausenC and KassemM. (2003). Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone, 33:919–926.
12.
CuiCH, UyamaT, MiyadoK, TeraiM, KyoS, KiyonoT and UmezawaA. (2007). Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol Biol Cell, 18:1586–1594.
NikooS, EbtekarM, Jeddi-TehraniM, ShervinA, BozorgmehrM, KazemnejadS and ZarnaniAH. (2012). Effect of menstrual blood-derived stromal stem cells on proliferative capacity of peripheral blood mononuclear cells in allogeneic mixed lymphocyte reaction. J Obstet Gynaecol Res, 38:804–809.
18.
MurphyMP, WangH, PatelAN, KambhampatiS, AngleN, ChanK, MarleauAM, PyszniakA, CarrierE, IchimTE and RiordanNH. (2008). Allogeneic endometrial regenerative cells: An “Off the shelf solution”. for critical limb ischemia?. J Transl Med, 6:45.
19.
HidaN, NishiyamaN, MiyoshiS, KiraS, SegawaK, UyamaT, MoriT, MiyadoK, IkegamiY, et al. (2008). Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells, 26:1695–1704.
20.
BorlonganCV, KanekoY, MakiM, YuSJ, AliM, AllicksonJG, SanbergCD, Kuzmin-NicholsN and SanbergPR. (2010). Menstrual blood cells display stem cell–like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev, 19:439–452.
21.
JiangZ, HuX, YuH, XuY, WangL, ChenH, ChenH, WuR, ZhangZ, et al. (2013). Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms. J Cell Mol Med, 17:1247–1260.
22.
XavierS, EfiEM, FengYZ, ErinW and HughST. (2011). Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Mol Ther, 19:2065–2071.
23.
LumelskyN, BlondelO, LaengP, VelascoI, RavinR and McKayR. (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science, 292:1389–1394.
24.
JiangW, ShiY, ZhaoDZ, ChenS, YongJ, ZhangJ, QingTT, SunX, ZhangP, et al. (2007). In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res, 17:333–334.
25.
KogaH, MunetaT, JuYJ, NagaseT, NimuraA, MochizukiT, IchinoseS, von der MarkK and SekiyaI. (2007). Synovial stem cells are regionally specified according to local microenvironments after implantation for cartilage regeneration. Stem Cells, 25:689–696.
26.
WiebkeS, FriedrichJH, MarcB, MatthiasH, AlexanderB, ClaudiaR, MarkusS, ThomasL, AndreasN, et al. (2008). Tracking of human cells in mice. Histochem Cell Bio, 130:329–338.
27.
GangEJ, BosnakovskiD, FigueiredoCA, VisserJW and PerlingeiroRC. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood, 109:1743–1751.
28.
Rosu-MylesM, McCullyJ, FairJ, MehicJ, MenendezP, RodriguezR and WestwoodC. (2013). The globoseries glycosphingolipid SSEA-4 is a marker of bone marrow-derived clonal multipotent stromal cells in vitro and in vivo. Stem Cells Dev, 22:1387–1397.
29.
HussR and MoosmannS. (2002). The co-expression of CD117 (c-kit) and osteocalcin in activated bone marrow stem cells in different diseases. Br J Haematol, 118:305–312.
30.
RomanovYA, DarevskayaAN, MeralikinaNV and BuravkovaLB. (2005). Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities. Bull Exp Biol Med, 140:138–143.
31.
GrajalesL, GarcíaJ, BanachK and GeenenDL. (2010). Delayed enrichment of mesenchymal cells promotes cardiac lineage and calcium transient development. J Mol Cell Cardiol, 48:735–745.
32.
LuLL, LiuYJ, YangSG, ZhaoQJ, WangX, GongW, HanZB, XuZS, LuYX, et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91:1017–1026.
33.
BellGI, BroughtonHC, LevacKD, AllanDA, XenocostasA and HessDA. (2012). Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem cells Dev, 21:97–109.
34.
KoblasT, ZacharovováK, BerkováZ, LeontovicI, DovolilováE, ZámecníkL and SaudekF. (2009). In vivo differentiation of human umbilical cord blood-derived cells into insulin-producing β cells. Folia Biol, 55:224–232.
35.
LenzenS. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51:216–226.
36.
SzkudelskiT. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res, 50:537–546.
CnopM, WelshN, JonasJC, JörnsA, LenzenS and EizirikDL. (2005). Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes, 54(Suppl 2):S97–S107.
39.
LenzenS, DrinkgernJ and TiedgeM. (1996). Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med, 20:463–466.
40.
HalliwellB and WhitemanM. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol, 142:231–255.
41.
ChenMF, LinCT, ChenWC, YangCT, ChenCC, LiaoSK, LiuJM, LuCH and LeeKD. (2006). The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys, 66:244–253.
42.
Valle-PrietoA and CongetPA. (2010). Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev, 19:1885–1893.
LinP, ChenL, YangN, SunY and XuYX. (2009). Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells. J Transplant Proc, 41:1891–1893.
46.
KuboA, StullR, TakeuchiM, BonhamK, Gouon-EvansV, ShoM, IwanoM, SaitoY, KellerG and SnodgrassR. (2011). Pdx1 and Ngn3 overexpression enhances pancreatic differentiation of mouse ES cell-derived endoderm population. PLoS One, 6:e24058.
47.
GradwohlG, DierichA, LeMeurM and GuillemotF. (2000). Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A, 97:1607–1611.
48.
SchwitzgebelVM, ScheelDW, ConnersJR, KalamarasJ, LeeJE, AndersonDJ, SusselL, JohnsonJD and GermanMS. (2000). Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development, 127:3533–3542.
49.
XuX, D'HokerJ, StangéG, BonnéS, De LeuN, XiaoX, Van de CasteeleM, MellitzerG, LingZ, et al. (2008). β cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell, 132:197–207.
50.
LiWC, RukstalisJM, NishimuraW, TchipashviliV, HabenerJF, SharmaA and Bonner-WeirS. (2010). Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats. J Cell Sci, 123:2793–2802.
51.
InadaA, NienaberC, KatsutaH, FujitaniY, LevineJ, MoritaR, SharmaA and Bonner-WeirS. (2008). Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A, 105:19915–19919.
52.
GuG, DubauskaiteJ and MeltonDA. (2002). Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development, 129:2447–2457.
53.
XuYX, ChenL, WangR, HouWK, LinP, SunL, SunY and DongQY. (2008). Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses, 71:390–393.
